相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling
Martin C. Moncrieffe et al.
STRUCTURE (2020)
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
Carlo Visco et al.
CANCERS (2020)
MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications
Ruben A. L. de Groen et al.
HAEMATOLOGICA (2019)
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells
Tomasz Sewastianik et al.
BLOOD ADVANCES (2019)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
CANCER ETIOLOGY Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Cristian Tomasetti et al.
SCIENCE (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
Reconstructing the TIR Side of the Myddosome: a Paradigm for TIR-TIR Interactions
Laurens Vyncke et al.
STRUCTURE (2016)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling
Hidenori Ohnishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
